Linda Keil studied Molecular and Applied Biotechnology at RWTH Aachen University and completed her master’s degree in 2020. During her master’s thesis, she focused on the formation of tumor spheroids and investigated the influence of extracellular matrix components and stromal cells. She then earned her Ph.D. in Synthetic Biotechnology at the Technical University of Munich. Her research focused on the quantitative analysis of biological systems and the evaluation of biotechnological applications.

Since April 2024, Linda Keil has been working as an IP Licensing Manager at Bayerische Patentallianz GmbH. There, she evaluates life science inventions in terms of their technical and commercial potential, develops marketing and partnering strategies, and oversees licensing and collaboration processes. In addition, she advises researchers and startups on IP strategy and commercialization.

Previously, as a working student at Positron Ventures, she gained experience in technology and startup scouting as well as in evaluating innovative business models and scientific technologies. Her particular interests lie at the intersection of life sciences, oncology, innovation, and the translation of scientific findings into commercial applications.